Latest News

Q2 2024 Watch: Prior authorization rollbacks in Medicaid HCV programs; ADAP and assistance program coverage.

Q1 2024 Watch: Pandemic Medicaid protections ended; millions lost coverage; ADAP and veterans updates.

Q4 2023 Watch: Bipartisan PEPFAR reauthorization push; ADAP coverage and Medicaid updates tracked.

Q3 2023 Watch: HIV disparities coverage; debt ceiling crisis impacts; Medicaid disenrollment trends tracked.

Q2 2023 Watch: Braidwood decision impacts PrEP coverage; ADAP coverage analysis and Medicaid program updates.

Q1 2023 Watch: Tennessee rejecting federal HIV funding; updates on ADAPs, Medicaid, veterans care, and harm reduction.

Q4 2022 Watch: HHS renewed opioid emergency; CANN launched monkeypox project; HEPLISAV-B hepatitis B vaccine covered.

European Commission approves lenacapavir, a novel six-month injectable for treatment-resistant HIV.

FDA reclassifies HCV testing to reduce regulatory burden and enable new test makers to enter market.

COVID-19 vaccination priority for people with HIV and chronic liver disease amid immunological risks.

FDA approves Cabenuva, first long-acting injectable HIV regimen offering monthly alternative to daily pills.

Final rule allowing drug importation from Canada poses safety risks from counterfeit medications.